Ray Sumita: insider trades.
Ray Sumita reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($266K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Ray Sumita
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cue Biopharma, Inc. (CUE) | Officer, Other · Chief Legal Compliance Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-13 | Cue Biopharma, Inc. | S | 2,383 | $29.37 | 124,991 | Form 4 |
| 2026-08-13 | Cue Biopharma, Inc. | M | 18,196 | $0 | 127,374 | Form 4 |
| 2026-08-13 | Cue Biopharma, Inc. | S | 6,442 | $30.35 | 118,549 | Form 4 |
| 2026-08-13 | Cue Biopharma, Inc. | S | 4 | $31.13 | 118,545 | Form 4 |
| 2026-07-09 | Cue Biopharma, Inc. | A | 54,589 | $0 | 109,178 | Form 4 |
Questions
What stock did Ray Sumita buy or sell?
Ray Sumita reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($266K), across 1 company.
Is Ray Sumita the same person as other filers with this name?
This page covers SEC CIK 1579629 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/ray-sumita-1579629.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.